Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-10-14

Clinical Trial Update: D-Cycloserine-Enhancer of One-Session Treatment for Phobia of Heights [NA]

View source ↗

Summary

A clinical trial evaluating D-Cycloserine as an enhancer of a one-session exposure treatment for height phobia (acrophobia); current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • D-cycloserine (D-cycloserine)

Snippet

Sponsor: CAMC Health System | Conditions: Height Phobia | NA | Status: UNKNOWN